| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |